Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Skin Burns and Fire Risks From Electroshock Treatment Device, Report Warns

CCHR investigation also finds potential dangerous billing for ECT


News provided by

Citizens Commission on Human Rights

Aug 29, 2018, 08:00 ET

Share this article

Share toX

Share this article

Share toX

LOS ANGELES, Aug. 29, 2018 /PRNewswire/ -- The mental health watchdog group Citizens Commission on Human Rights (CCHR) is warning insurance companies, including Medicaid, to be alert to potential fraudulent claims for the use of electroconvulsive therapy — electroshock treatment (ECT) — for conditions not cleared by the Food and Drug Administration (FDA). Such claims could be putting patients at additional risk from the ECT device that delivers up to 460 volts of electricity to the brain causing a grand mal seizure. The device is currently under scrutiny over the FDA's failure to meet Congressional mandates to ensure the high-risk Class III ECT devices are proven safe and effective.

Continue Reading
CCHR investigation also finds potential dangerous billing for ECT
CCHR investigation also finds potential dangerous billing for ECT

A state Patient Safety Authority report on ECT reveals an anesthesiologist and nurse reported burns to skin and hair during the ECT procedure. In one report of a fire, "a bright flash and flames were noted on the right side of the patient's head at the instant that the ECT shock was given. Though the flames were quickly extinguished, the patient experienced first- and second-degree burns on one ear and first-degree burns on the forehead above one eye."[1]

The FDA reports serious adverse reactions linked to ECT that includes brain damage, memory loss, cognitive damage, cardiovascular complications and deaths, including suicide.[2]  Riding on the tragedies of recent celebrity suicides, one renowned ECT advocate, with ties to the two manufacturers of the device, is shamelessly claiming ECT is "underutilized," and it is "easier to get a gun than a prescription for ECT." Yet, based on Texas reports of ECT usage and death, an estimated 300 ECT recipients may die each year, including by suicide likely prompted by the ECT. In one study, the suicide rate linked to ECT was a whopping 27 percent, CCHR reports.

In April this year, a Melbourne, Australia, coroner ruled a suicide following ECT was preventable because the treatment had imposed further pain, discomfort, stress and a sense of hopelessness in the 62-year-old grandfather who did not want to undergo ECT but was forced to involuntarily.[3]

Despite damaging and long-term side effects, and without clinical trials proving safety, the FDA has allowed the device to stay on the market for the treatment of six alleged disorders. Yet CCHR says psychiatrists have prescribed ECT way outside these parameters, placing even more patients at risk.

The Centers for Medicare and Medicaid Services (CMS) covers treatment for about three disorders, but the dangerous device is used to prescribe "off-label" (not FDA-approved) conditions for which private insurance, Medicaid and Medicare can be billed.

Dr. Charles Kellner, professor in the department of psychiatry at the Icahn School of Medicine at Mount Sinai, estimates that if the FDA limits the use of the ECT device, based on a proposal it made in 2015, it could reduce the 100,000 Americans being electroshocked each year by 40 percent, and insurance companies may exclude "off-label use of ECT, malpractice insurance companies [could] refuse to cover doctors who provide it, or hospital administrators [could] prohibit their ECT providers from administering it."

Jan Eastgate, president of CCHR International, says that essentially psychiatrists are marketing the idea to prescribe ECT off-label because the FDA does not regulate their practices, no matter how damaging they may be. She said, "In reality, it is not about patients but profits, with a potential 40 percent loss representing a $2.16 billion financial loss to the annual shock treatment industry."

CCHR's ongoing investigation shows ECT is being used off-label and possibly insurance companies being billed to treat autism, Post Traumatic Stress Disorder, chronic pain, addiction and Alzheimer's disease and dementia — the latter both conditions characterized by cognitive or memory deterioration that ECT can exacerbate. Astoundingly, CCHR says, patients testify that ECT destroys memory, yet it is being used experimentally to eradicate "painful memories."

Eastgate further states: "Psychiatrists try to pass off severe and debilitating memory loss from ECT as transient while acknowledging it as being capable of wiping out memory."

She also cited a group of researchers at Rutgers University that have experimented in using ECT to erase fear memories of being shocked in rats.[4]

Studies reported on clinicaltrials.gov show that ECT being given to those with Alzheimer's disease using a U.S. ECT device, which has yet to be FDA-approved by clinical trial, as safe.[v] Says Eastgate, "Frail elderly people, already disturbed by failing memory and cognitive deterioration are being subjected to the violence of electroshock, renowned for decades to harm memory and cause premature death in the elderly."

Other studies on the government clinical trials website show that Johns Hopkins University and Johns Hopkins Bloomberg School of Public Health sponsored a study aimed at "decreasing" (not eliminating) unmodified ECT being administered at India's Chhatrapati Shahuji Maharaj Medical University hospital. Banned in India only last year, unmodified ECT, which is administered without anesthetic and muscle relaxer, can result in a fractured spine and death. In the 2012 study, anesthetic was offered to patients, hypothesizing that the added cost would not be prohibitive to the hospital, while study subjects were monitored for occurrences of "fractures and dislocations," among other adverse effects in the group not given anesthetic.

Reportedly no longer practiced in the U.S. because of the potential lethal risk, unmodified ECT is still used in developing and poor countries, despite the United Nations committee on torture condemning it as torture and ill-treatment.[6]

Yet the U.S. Journal of ECT published a study about unmodified ECT in Pakistan, concluding that "although administering ECT without anesthesia is not desirable, in the face of severe economic constraints, it is often necessary." [Emphasis added] 

The editorial board of the journal includes a divisional director of the U.S. National Institute of Mental Health (NIMH) who oversees approximately $400 million in research funds and a prolific administrator and researcher of ECT in the U.S., who was among other high-profile ECT psychiatrists that issued a positioning statement in 2013 claiming that unmodified ECT could be performed only under "exceptional circumstances."

The Journal's editorial members have also included several psychiatrists that own a U.S. ECT device company which distributes the device to more than 60 countries, many delivering electroshock without anesthetic or muscle relaxant, including Japan.

"Unmodified ECT is a moot point," Eastgate adds. "You can't replace one torture with another — ECT with anesthetic. Doctors cannot claim that electric shock on prisoners is torture, but if given to patients in a hospital or outpatient clinic with an anesthetic, that torture becomes therapy. It's akin to knocking a person unconscious before battering them then claiming it's not grounds for assault because they were 'asleep.' Under both circumstances, the person is going to wake up damaged. The whole thing is torture and the electroshock procedure and any of its offshoots need to be banned." 

CCHR says Congress should be investigating any complicity between FDA officials, psychiatrists and ECT device makers that has allowed a high-risk Class III device to remain on the market. In the meantime, Medicare, Medicaid and private insurance companies need to be alert to the off-label recommendations for ECT and not approve these. CCHR's online petition continues to gain increasing support for a total ban.

CCHR is a non-profit mental health watchdog group dedicated to eliminating abuses committed under the guise of mental health. CCHR works to ensure patient and consumer protections are enacted and upheld as there is rampant abuse in the field of mental health. In this role, CCHR has helped to enact more than 180 laws protecting individuals from abusive or coercive mental health practices since it was formed over 49 years ago, including a ban on electroshock use on children in four U.S. states and in Western Australia.

Contact: Amber Rauscher, [email protected] or (323) 467-4242.

References:

[1] "Skin Burns and Fires during Electroconvulsive Therapy Treatments," PA Patient Safety Authority, Patient Saf Advis 2007 Mar;4(1):25-6, http://patientsafety.pa.gov/ADVISORIES/Pages/200703_25.aspx.

[2] FDA ECT Exec Summary, Jan. 2011, page 15; https://www.cchrint.org/2016/03/10/stop-fdas-plan-for-ect-treatment/.

[3] https://www.theage.com.au/national/victoria/grandfather-forced-to-undergo-ect-before-preventable-death-20180418-p4zacy.html.

[4] "Can We Erase Painful Memories with Electroconvulsive Therapy?" Harvard University Magazine, 1 Oct. 2017, http://sitn.hms.harvard.edu/flash/2017/can-erase-painful-memories-electroconvulsive-therapy/.

[5] https://clinicaltrials.gov/ct2/show/NCT02438202.

[6] "Torture and other cruel, inhuman or degrading treatment or punishment," United Nations, 28 July 2008.

Related Links

Sign the Petition to Ban Electroshock (ECT) Device Being Used on Children, the Elderly and Vulnerable Patients

Find Out About the Documented Facts & Statistics About Modern Electroshock (ECT)

Related Video

http://www.youtube.com/watch?v=rgyZmG143Oc

SOURCE Citizens Commission on Human Rights

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.